Human T-lymphotropic virus-1 is a preventable sexually transmitted infection. In the majority of people it is asymptomatic, remaining undiagnosed and thereby contributing to its silent transmission. When it does manifest it causes significant morbidity and mortality. This review summarises the existing evidence for its role in sexual transmission and offers suggestions for those working in the area of sexual health. This is the third part of a series looking at novel sexually transmitted infections.
PoieszBJRuscettiFWGazdarAF, et al.
Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA1980;
77: 7415–7419.
2.
KalyanaramanVSSarngadharanMGRobert-GuroffM, et al.
A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. Science1982;
218: 571–573.
3.
GessainARuaRBetsemE, et al.
HTLV-3/4 and simian foamy retroviruses in humans: discovery, epidemiology, cross-species transmission and molecular virology. Virology2013;
435: 187–199.
4.
GessainACassarO.Epidemiological aspects and world distribution of HTLV-1 infection. Front Microbiol2012;
3: 388.
RoucouxDFWangBSmithD, et al.
A prospective study of sexual transmission of human T lymphotropic virus (HTLV)-I and HTLV-II. J Infect Dis2005;
191: 1490–1497.
8.
GotuzzoESanchezJEscamillaJ, et al.
Human T cell lymphotropic virus type I infection among female sex workers in Peru. J Infect Dis1994;
169: 754–759.
9.
ZehenderGColasanteCDe MaddalenaC, et al.
High prevalence of human T-lymphotropic virus type 1 (HTLV-1) in immigrant male-to-female transsexual sex workers with HIV-1 infection. J Med Virol2004;
74: 207–215.
10.
BeriniCAPandoMABautistaCT, et al.
HTLV-1/2 among high-risk groups in Argentina: molecular diagnosis and prevalence of different sexual transmitted infections. J Med Virol2007;
79: 1914–1920.
11.
DelaporteEBuveANzilaN, et al.
HTLV-I infection among prostitutes and pregnant women in Kinshasa, Zaire: how important is high-risk sexual behavior?J Acquir Immune Defic Syndr Hum Retrovirol1995;
8: 511–515.
12.
NakashimaKKashiwagiSKajiyamaW, et al.
Sexual transmission of human T-lymphotropic virus type I among female prostitutes and among patients with sexually transmitted diseases in Fukuoka, Kyushu, Japan. Am J Epidemiol1995;
141: 305–311.
13.
KhabbazRFDarrowWWHartleyTM, et al.
Seroprevalence and risk factors for HTLV-I/II infection among female prostitutes in the United States. JAMA1990;
263: 60–64.
14.
VerdierMDenisFSangareA, et al.
Prevalence of antibody to human T cell leukemia virus type 1 (HTLV-1) in populations of Ivory Coast, West Africa. J Infect Dis1989;
160: 363–370.
15.
WignallFSHyamsKCPhillipsIA, et al.
Sexual transmission of human T-lymphotropic virus type I in Peruvian prostitutes. J Med Virol1992;
38: 44–48.
16.
La RosaAMZuntJRPeinadoJ, et al.
Retroviral infection in Peruvian men who have sex with men. Clin Infect Dis2009;
49: 112–117.
17.
StuverSOTachibanaNOkayamaA, et al.
Heterosexual transmission of human T cell leukemia/lymphoma virus type I among married couples in southwestern Japan: an initial report from the Miyazaki Cohort Study. J Infect Dis1993;
167: 57–65.
18.
KajiyamaWKashiwagiSIkematsuH, et al.
Intrafamilial transmission of adult T cell leukemia virus. J Infect Dis1986;
154: 851–857.
19.
TosswillJHTaylorGPTedderRS, et al.
HTLV-I/II associated disease in England and Wales, 1993–7: retrospective review of serology requests. BMJ2000;
320: 611–612.
20.
AdesAEParkerSWalkerJ, et al.
Human T cell leukaemia/lymphoma virus infection in pregnant women in the United Kingdom: population study. BMJ2000;
320: 1497–1501.
OrlandJREngstromJFrideyJ, et al.
Prevalence and clinical features of HTLV neurologic disease in the HTLV outcomes study. Neurology2003;
61: 1588–1594.
23.
KaplanJEOsameMKubotaH, et al.
The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I. J Acquir Immune Defic Syndr1990;
3: 1096–1101.
24.
GoncalvesDUProiettiFARibasJG, et al.
Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1-associated diseases. Clin Microbiol Rev2010;
23: 577–589.
25.
EinsiedelLCassarOGoemanE, et al.
Higher human T-lymphotropic virus type 1 subtype C proviral loads are associated with bronchiectasis in indigenous Australians: results of a case-control study. Open Forum Infect Dis2014;
1: ofu023.
26.
LarocqueEHalinMLandryS, et al.
Human T-cell lymphotropic virus type 3 (HTLV-3)- and HTLV-4-derived antisense transcripts encode proteins with similar Tax-inhibiting functions but distinct subcellular localization. J Virol2011;
85: 12673–12685.
BuschMPLaycockMKleinmanSH, et al.
Accuracy of supplementary serologic testing for human T-lymphotropic virus types I and II in US blood donors. Retrovirus Epidemiology Donor Study. Blood1994;
83: 1143–1148.
29.
LipkaJJMiyoshiIHadlockKG, et al.
Segregation of human T cell lymphotropic virus type I and II infections by antibody reactivity to unique viral epitopes. J Infect Dis1992;
165: 268–272.
30.
IrelandGCroxfordSTosswillJ, et al.
Human T-lymphotropic viruses (HTLV) in England and Wales, 2004 to 2013: testing and diagnoses. Euro Surveill2017;
22(21): pii = 30539.
31.
IzumoSGotoIItoyamaY, et al.
Interferon-alpha is effective in HTLV-I-associated myelopathy: a multicenter, randomized, double-blind, controlled trial. Neurology1996;
46: 1016–1021.
32.
TaylorGPGoonPFurukawaY, et al.
Zidovudine plus lamivudine in human T-lymphotropic virus type-I-associated myelopathy: a randomised trial. Retrovirology2006;
3: 63.
33.
MartinFCastroHGabrielC, et al.
Ciclosporin A proof of concept study in patients with active, progressive HTLV-1 associated myelopathy/tropical spastic paraparesis. PLoS Negl Trop Dis2012;
6: e1675.
34.
HarringtonWJJrSheremataWASnodgrassSR, et al.
Tropical spastic paraparesis/HTLV-1-associated myelopathy (TSP/HAM): treatment with an anabolic steroid danazol. AIDS Res Hum Retroviruses1991;
7: 1031–1034.
35.
BuellKGPuriADemontisMA, et al.
Effect of pulsed methylprednisolone on pain, in patients with HTLV-1-associated myelopathy. PLoS One2016;
11: e0152557.
36.
SatoTColer-ReillyALGYagishitaN, et al.
Mogamulizumab (Anti-CCR4) in HTLV-1-associated myelopathy. N Engl J Med2018;
378: 529–538.
37.
BazarbachiAPlumelleYCarlos RamosJ, et al.
Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia/lymphoma showing improved survival in the leukemic subtypes. J Clin Oncol2010;
28: 4177–4183.
38.
IshidaTIidaSAkatsukaY, et al.
The CC chemokine receptor 4 as a novel specific molecular target for immunotherapy in adult T-cell leukemia/lymphoma. Clin Cancer Res2004;
10: 7529–7539.
39.
IshidaTUtsunomiyaAJoT, et al.
Mogamulizumab for relapsed adult T-cell leukemia-lymphoma: updated follow-up analysis of phase I and II studies. Cancer Sci2017;
108: 2022–2029.
40.
YamamotoKUtsunomiyaATobinaiK, et al.
Phase I study of KW-0761, a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma. J Clin Oncol2010;
28: 1591–1598.
41.
SharmaKJanikJEO’MahonyD, et al.
Phase II study of alemtuzumab (CAMPATH-1) in patients with HTLV-1-associated adult T-cell leukemia/lymphoma. Clin Cancer Res2017;
23: 35–42.
42.
BerkowitzJLJanikJEStewartDM, et al.
Safety, efficacy, and pharmacokinetics/pharmacodynamics of daclizumab (anti-CD25) in patients with adult T-cell leukemia/lymphoma. Clin Immunol2014;
155: 176–187.
43.
KatsuyaHIshitsukaKUtsunomiyaA, et al.
Treatment and survival among 1594 patients with ATL. Blood2015;
126: 2570–2577.
44.
WatanabeT.Adult T-cell leukemia: molecular basis for clonal expansion and transformation of HTLV-1-infected T cells. Blood2017;
129: 1071–1081.
45.
PaivaACassebJ.Sexual transmission of human T-cell lymphotropic virus type 1. Rev Soc Bras Med Trop2014;
47: 265–274.
46.
YamadaTTogashiTTsutsumiH, et al.
Prevalence of human T-lymphotropic virus type 1 carriers among pregnant women in Hokkaido, Japan. Microbiol Immunol2014;
58: 427–431.
47.
TangARTaylorGPDhasmanaD.Self-flagellation as possible route of human T-cell lymphotropic virus type-1 transmission. Emerg Infect Dis2019;
25: 811–813.
48.
OkochiKSatoH.Transmission of adult T-cell leukemia virus (HTLV-I) through blood transfusion and its prevention. AIDS Res1986;
2: S157–S161.
49.
BittencourtAL.Vertical transmission of HTLV-I/II: a review. Rev Inst Med Trop S Paulo1998;
40: 245–251.
TaylorGP.Human T-lymphotropic virus type 1 infection and solid organ transplantation. Rev Med Virol2018;
28: e1970.
53.
LapercheSPillonelJ.[Relevance of safety measures to avoid HTLV transmission by transfusion in 2014]. Transfus Clin Biol2014;
21: 167–172.
54.
HewittPEDavisonKHowellDR, et al.
Human T-lymphotropic virus lookback in NHS blood and transplant (England) reveals the efficacy of leukoreduction. Transfusion2013;
53: 2168–2175.
55.
TsujiYDoiHYamabeT, et al.
Prevention of mother-to-child transmission of human T-lymphotropic virus type-I. Pediatrics1990;
86: 11–17.
56.
WiktorSZPateEJRosenbergPS, et al.
Mother-to-child transmission of human T-cell lymphotropic virus type I associated with prolonged breast-feeding. J Hum Virol1997;
1: 37–44.
57.
LiHCBiggarRJMileyWJ, et al.
Provirus load in breast milk and risk of mother-to-child transmission of human T lymphotropic virus type I. J Infect Dis2004;
190: 1275–1278.
58.
BiggarRJNgJKimN, et al.
Human leukocyte antigen concordance and the transmission risk via breast-feeding of human T cell lymphotropic virus type I. J Infect Dis2006;
193: 277–282.
59.
HinoS.Establishment of the milk-borne transmission as a key factor for the peculiar endemicity of human T-lymphotropic virus type 1 (HTLV-1): the ATL Prevention Program Nagasaki. Proc Jpn Acad Ser B2011;
87: 152–166.
60.
Ureta-VidalAAngelin-DuclosCTortevoyeP, et al.
Mother-to-child transmission of human T-cell-leukemia/lymphoma virus type I: implication of high antiviral antibody titer and high proviral load in carrier mothers. Int J Cancer1999;
82: 832–836.
61.
HinoSKatamineSKawaseK, et al.
Intervention of maternal transmission of HTLV-1 in Nagasaki, Japan. Leukemia1994;
8: S68–S70.
62.
BittencourtALSabinoECCostaMC, et al.
No evidence of vertical transmission of HTLV-I in bottle-fed children. Rev Inst Med Trop S Paulo2002;
44: 63–65.
63.
NyambiPNVilleYLouwagieJ, et al.
Mother-to-child transmission of human T-cell lymphotropic virus types I and II (HTLV-I/II) in Gabon: a prospective follow-up of 4 years. J Acquir Immune Defic Syndr Hum Retrovirol1996;
12: 187–192.
64.
KashiwagiKFurusyoNNakashimaH, et al.
A decrease in mother-to-child transmission of human T lymphotropic virus type I (HTLV-I) in Okinawa, Japan. Am J Trop Med Hyg2004;
70: 158–163.
65.
RosadasCMalikBTaylorGP, et al.
Estimation of HTLV-1 vertical transmission cases in Brazil per annum. PLoS Negl Trop Dis2018;
12: e0006913.
66.
ZuntJRDezzuttiCSMontanoSM, et al.
Cervical shedding of human T cell lymphotropic virus type I is associated with cervicitis. J Infect Dis2002;
186: 1669–1672.
67.
BelecLJean GeorgesAHallouinMC, et al.
Human T-lymphotropic virus type I excretion and specific antibody response in paired saliva and cervicovaginal secretions. AIDS Res Hum Retroviruses1996;
12: 157–167.
68.
MoriuchiMMoriuchiH.Seminal fluid enhances replication of human T-cell leukemia virus type 1: implications for sexual transmission. J Virol2004;
78: 12709–12711.
69.
GoutOBaulacMGessainA, et al.
Rapid development of myelopathy after HTLV-I infection acquired by transfusion during cardiac transplantation. N Engl J Med1990;
322: 383–388.
70.
GessainAGalloRCFranchiniG.Low degree of human T-cell leukemia/lymphoma virus type I genetic drift in vivo as a means of monitoring viral transmission and movement of ancient human populations. J Virol1992;
66: 2288–2295.
71.
IgaMOkayamaAStuverS, et al.
Genetic evidence of transmission of human T cell lymphotropic virus type 1 between spouses. J Infect Dis2002;
185: 691–695.
72.
SibonDCassarODugaI, et al.
Adult T-cell leukemia/lymphoma in a Caucasian patient after sexual transmission of human T-cell lymphotropic virus type 1. Open Forum Infect Dis2015;
2: ofv032.
73.
CaswellRJNallPBoothbyM, et al.
Rapid onset and progression of myelopathy following an STI: a case for screening?Sex Transm Infect2019;
95: 244–245.
74.
MannsAHisadaMLa GrenadeL.Human T-lymphotropic virus type I infection. Lancet1999;
353: 1951–1958.
75.
DouradoIAlcantaraLCBarretoML, et al.
HTLV-I in the general population of Salvador, Brazil: a city with African ethnic and sociodemographic characteristics. J Acquir Immune Defic Syndr1999;
2003: 527–531.
76.
MurphyELWilksRHanchardB, et al.
A case-control study of risk factors for seropositivity to human T-lymphotropic virus type I (HTLV-I) in Jamaica. Int J Epidemiol1996;
25: 1083–1089.
77.
RiedelDAEvansASSaxingerC, et al.
A historical study of human T lymphotropic virus type I transmission in Barbados. J Infect Dis1989;
159: 603–609.
78.
DouradoIAndradeTGalvao-CastroB.HTLV-I in Northeast Brazil: differences for male and female injecting drug users. J Acquir Immune Defic Syndr Hum Retrovirol1998;
19: 426–429.
79.
SatakeMIwanagaMSagaraY, et al.
Incidence of human T-lymphotropic virus 1 infection in adolescent and adult blood donors in Japan: a nationwide retrospective cohort analysis. Lancet Infect Dis2016;
16: 1246–1254.
80.
NunesDBoa-SorteNGrassiMF, et al.
HTLV-1 is predominantly sexually transmitted in Salvador, the city with the highest HTLV-1 prevalence in Brazil. PLoS One2017;
12: e0171303.
81.
StuverSOMuellerNE.Re: “Sexual transmission of human T-lymphotropic virus type I among female prostitutes and among patients with sexually transmitted diseases in Fukuoka, Kyushu, Japan”. Am J Epidemiol1995;
142: 1247–1248.
82.
FigueroaJPWardEMorrisJ, et al.
Incidence of HIV and HTLV-1 infection among sexually transmitted disease clinic attenders in Jamaica. J Acquir Immune Defic Syndr Hum Retrovirol1997;
15: 232–237.
83.
KaplanJEKhabbazRFMurphyEL, et al.
Male-to-female transmission of human T-cell lymphotropic virus types I and II: association with viral load. The Retrovirus Epidemiology Donor Study Group. J Acquir Immune Defic Syndr Hum Retrovirol1996;
12: 193–201.
84.
MelbyeMPoulsenAGGalloD, et al.
HTLV-1 infection in a population-based cohort of older persons in Guinea-Bissau, West Africa: risk factors and impact on survival. Int J Cancer1998;
76: 293–298.
85.
WilliamsBGLloyd-SmithJOGouwsE, et al.
The potential impact of male circumcision on HIV in Sub-Saharan Africa. PLoS Med2006;
3: e262.
86.
MurphyELFigueroaJPGibbsWN, et al.
Sexual transmission of human T-lymphotropic virus type I (HTLV-I). Ann Intern Med1989;
111: 555–560.
87.
ZuntJRLa RosaAMPeinadoJ, et al.
Risk factors for HTLV-II infection in Peruvian men who have sex with men. Am J Trop Med Hyg2006;
74: 922–925.
88.
TurnerCGCohenCESabinCA, et al.
The seroepidemiology of HTLV-I amongst genitourinary medicine (GUM) attendees in South East London. J Clin Virol2008;
43: 253–254.
89.
KhabbazRFOnoratoIMCannonRO, et al.
Seroprevalence of HTLV-1 and HTLV-2 among intravenous drug users and persons in clinics for sexually transmitted diseases. N Engl J Med1992;
326: 375–380.
90.
GuimaraesMLBastosFITellesPR, et al.
Retrovirus infections in a sample of injecting drug users in Rio de Janeiro City, Brazil: prevalence of HIV-1 subtypes, and co-infection with HTLV-I/II. J Clin Virol2001;
21: 143–151.
91.
CookeFJGerettiAMZuckermanM.Human T-cell lymphotropic virus antibody prevalence in HIV-1-infected individuals attending a sexual health clinic in South-East London. J Med Virol2005;
76: 143–145.
